『Impella CP: Can Microaxial Flow Pumps Redefine Cardiogenic Shock Treatment? Insights from the DanGer Shock Study』のカバーアート

Impella CP: Can Microaxial Flow Pumps Redefine Cardiogenic Shock Treatment? Insights from the DanGer Shock Study

Impella CP: Can Microaxial Flow Pumps Redefine Cardiogenic Shock Treatment? Insights from the DanGer Shock Study

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

In this episode, we explore the DanGer Shock study, which investigated the efficacy of the microaxial flow pump Impella CP in reducing mortality and improving clinical outcomes in patients with STEMI-related cardiogenic shock. We delve into the study's design, statistical findings, clinical recommendations, and the future of mechanical circulatory support in cardiology, highlighting both the benefits and risks of this advanced technology as published in the NEJM.


Links to the Podcast

  • Apple Podcast:⁠⁠⁠Listen on Apple Podcast⁠⁠⁠
  • Spotify:⁠⁠⁠Listen on Spotify⁠⁠⁠
  • Amazon Music:⁠⁠⁠Listen on Amazon Music⁠⁠⁠
  • YouTube:⁠⁠⁠Watch on YouTube⁠⁠⁠


📚 Source:
Study Title: Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock (DanGer Shock Trial)
Publication Date: April 2024
Journal: NEJM
DOI:10.1056/NEJMoa2312572


#MedicalPodcast #Cardiology #CardiogenicShock #ImpellaCP #DanGerShockStudy #MyocardialInfarction #MicroaxialFlowPump #CirculatorySupport #NEJM #HeartFailure #ClinicalResearch #HeartDevices #Podcast


Impella CP: Can Microaxial Flow Pumps Redefine Cardiogenic Shock Treatment? Insights from the DanGer Shock Studyに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。